SELLAS Life Sciences Group, Inc. (SLS)

4.32 +0.34 (+8.54%) USD  |  NASDAQ  |  Jan 20, 16:00
4.31 -0.01 (-0.23%) Pre-Market: 08:25
More

SELLAS Life Sciences Group Current Provisions - Legal & Other (Per Share)

Current Provisions - Legal & Other (Per Share) Chart

View Current Provisions - Legal & Other (Per Share) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Provisions - Legal & Other (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Provisions - Legal & Other (Per Share) Range, Past 5 Years

View Current Provisions - Legal & Other (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Provisions - Legal & Other (Per Share) Benchmarks

View Current Provisions - Legal & Other (Per Share) Benchmarks
Start Trial
GT Biopharma, Inc. --
Amicus Therapeutics, Inc. --
Geron Corp. --
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. --